Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

Ads

You May Also Like

Genocea to Present at Two March Investor Conferences

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

ASTRAZENECA PLC ANNOUNCES MEDIMMUNE OUT-LICENSES POTENTIAL MEDICINE FOR INFLAMMATORY DISEASES TO ALLERGAN

This announcement contains inside information 03 October 2016 07:00 AstraZeneca today announced that MedImmune, ...

Orion Corporation’s publication schedules for financial reporting in 2017

ORION CORPORATION      STOCK EXCHANGE RELEASE 19 JULY 2016 at 11:00 a.m. EEST               Orion ...